Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Gastroenterol ; 11: 17, 2011 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-21385443

RESUMO

BACKGROUND: Antipsychotic are the cornerstone in the treatment of schizophrenia. They also have a number of side-effects. Constipation is thought to be common, and a potential serious side-effect, which has received little attention in recent literature. METHOD: We performed a retrospective study in consecutively admitted patients, between 2007 and 2009 and treated with antipsychotic medication, linking different electronic patient data to evaluate the prevalence and severity of constipation in patients with schizophrenia under routine treatment conditions. RESULTS: Over a period of 22 months 36.3% of patients (99) received at least once a pharmacological treatment for constipation. On average medication for constipation was prescribed for 273 days. Severe cases (N = 50), non-responsive to initial treatment, got a plain x-ray of the abdomen. In 68.4% fecal impaction was found. CONCLUSION: A high prevalence of constipation, often severe and needing medical interventions, was confirmed during the study period. Early detection, monitoring over treatment and early intervention of constipation could prevent serious consequences such as ileus.


Assuntos
Antipsicóticos/efeitos adversos , Antipsicóticos/uso terapêutico , Constipação Intestinal/induzido quimicamente , Constipação Intestinal/epidemiologia , Esquizofrenia/tratamento farmacológico , Índice de Gravidade de Doença , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Aripiprazol , Clozapina/efeitos adversos , Clozapina/uso terapêutico , Constipação Intestinal/tratamento farmacológico , Enema , Impacção Fecal/induzido quimicamente , Impacção Fecal/tratamento farmacológico , Impacção Fecal/epidemiologia , Feminino , Fármacos Gastrointestinais/uso terapêutico , Humanos , Lactulose/uso terapêutico , Masculino , Pessoa de Meia-Idade , Piperazinas/efeitos adversos , Piperazinas/uso terapêutico , Polietilenoglicóis/uso terapêutico , Prevalência , Quinolonas/efeitos adversos , Quinolonas/uso terapêutico , Estudos Retrospectivos , Risperidona/efeitos adversos , Risperidona/uso terapêutico , Adulto Jovem
2.
Acta Biomed ; 78(2): 144-8, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17933283

RESUMO

Aim of this article is to describe the first italian case reported in literature of a clozapine-induced intestinal occlusion with previous severe constipation in a 45-year-old male patient who had been treated with daily clozapine for 5 months because of treatment-resistant residual schizophrenia. When conservative treatment (intravenous fluids, fleet enema and rectal washout) was used and clozapine therapy was decreased, gastrointestinal symptoms rapidly improved and the patient had regular bowel motions within a week. Preventive measures (high-fiber diet, adequate fluid intake, stool softeners and exercise) was also used to ensure that clozapine therapy could be safely continued. Although constipation is a common and usually benign side effect of treatment with clozapine, this case-report highlights the consequences of undertreated and unrecognized marked constipation progressing to severe bowel obstruction (a complication which deserves more attention because it can lead to hospitalization and might be potentially fatal).


Assuntos
Antipsicóticos/efeitos adversos , Clozapina/efeitos adversos , Impacção Fecal/induzido quimicamente , Antipsicóticos/administração & dosagem , Antipsicóticos/sangue , Clozapina/administração & dosagem , Clozapina/sangue , Constipação Intestinal/induzido quimicamente , Impacção Fecal/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Esquizofrenia/tratamento farmacológico , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA